SLC5A2 and heart failure: Rates of heart failure medication were comparable in women and men, with slightly higher use of sodium–glucose cotransporter 2 (SGLT2) inhibitors and angiotensin receptor–neprilysin inhibitors (ARNI; sacubitril/valsartan) in men.